ArticlemedRxiv : the preprint server for health sciences2025
Incidentally discovered Covert Cerebrovascular Disease by CT versus MRI: Agreement and Prognostic Value for Stroke and Dementia in a Large Real-World Cohort.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Background: Covert cerebrovascular disease (CCD), comprising covert brain infarction (CBI) and white matter disease (WMD), is common in older adults and linked to increased risk of stroke and dementia. While most CCD research relies on MRI, CT remains the predominant imaging modality in clinical care. The influence of imaging modality on detection and prognosis of incidentally discovered CCD remains unclear. Methods: We identified 18,626 patients aged ≥50 years from Kaiser Permanente Southern California who underwent both CT and MRI brain scans within 30 days between 2009-2022. Patients with known prior stroke or dementia were excluded. Natural language processing algorithms were applied to radiology reports to identify CBI and WMD status and WMD severity (none, mild, moderate, severe). We assessed prevalence, cross-modality agreement (Cohen's kappa), and reclassification patterns. Prognostic associations with incident stroke or dementia were estimated using Cox Proportional Hazards regression adjusted for vascular and cognitive risk factors. Findings: CBI prevalence was similar for CT (6.3%) and MRI (6.1%), but agreement was modest (κ=0.27). WMD was reported far more often on MRI (60.5%) than CT (24.4%). Among 15,551 patients with classifiable severity on both modalities, 47.9% (n=7,441) had discordant grades, with 92.3% upgraded on MRI. The incidence rates of stroke or dementia per 1,000 person-years were 12.7 (95% CI 11.5 - 14.0) for patients without WMD on either modality (36.3% of the cohort), 22.6 (21.0 - 24.2) for WMD detected on MRI only (39.2% of the cohort), and 52.2 (48.69 to 55.95) for WMD detected on both CT and MRI (21.2% of the cohort). In adjusted Cox models, WMD detected on MRI only was associated with a 23% higher hazard of stroke or dementia (HR=1.23, 95% CI 1.07-1.41) compared with no WMD on either modality, while WMD detected on both CT and MRI was associated with an 82% higher hazard (1.82, 1.58-2.11). Interpretation: MRI detects substantially more WMD than CT; however, WMD visible on CT has stronger prognostic significance, despite CT's low sensitivity. These findings emphasize modality-based diagnostic and prognostic differences and support the need for modality-specific approaches when translating CCD research into clinical risk assessment and patient counselling.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.